Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Tax Provisions (2016 - 2026)

Apyx Medical filings provide 15 years of Tax Provisions readings, the most recent being $94000.0 for Q4 2025.

  • On a quarterly basis, Tax Provisions rose 5.62% to $94000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $270000.0, a 7.14% increase, with the full-year FY2025 number at $270000.0, up 7.14% from a year prior.
  • Tax Provisions hit $94000.0 in Q4 2025 for Apyx Medical, up from $78000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $151000.0 in Q4 2022 to a low of -$2.3 million in Q1 2023.
  • Median Tax Provisions over the past 5 years was $68000.0 (2021), compared with a mean of -$58150.0.
  • Biggest five-year swings in Tax Provisions: skyrocketed 133.25% in 2021 and later plummeted 3338.57% in 2023.
  • Apyx Medical's Tax Provisions stood at $134000.0 in 2021, then rose by 12.69% to $151000.0 in 2022, then plummeted by 42.38% to $87000.0 in 2023, then rose by 2.3% to $89000.0 in 2024, then grew by 5.62% to $94000.0 in 2025.
  • The last three reported values for Tax Provisions were $94000.0 (Q4 2025), $78000.0 (Q3 2025), and $49000.0 (Q2 2025) per Business Quant data.